PREDICTING IGA NEPHROPATHY PROGRESSION: A HISTOPATHOLOGICAL APPROACH USING PARIETAL EPITHELIAL CELLS AND PODOCYTE MARKERS - PARCC IgAN Score

Certificate Output Instructions

For best output, select "Paper Size" as "A4" and "Margin" as "0" or "None".

To save or print to PDF, please select Print Destination > Save as PDF, enable Background Graphics under "More Settings", then click "Save".

Presented the abstract " "
(Abstract co-author(s): )

Back

E-Poster Presentation

During the congress, E-Posters will be accessible to all participants on the congress website 24/7, as well as in the E-poster stations in the congress center.

Preparing your E-Poster

Please review the E-Poster format requirements carefully when preparing your E-Poster. Should your E-Poster not meet the mentioned requirements, it may not be displayed as described above.

E-Poster Submission Deadline

Please prepare and upload your E-Poster no later than March 14, 2026 11.59PM CET. After this date, you will no longer be able to prepare and upload your E-poster and it will not be displayed and accessible on the congress website.

E-Poster Format Requirements

PDF file
Layout: Portrait (vertical orientation)
One page only (Dim A4: 210 x 297mm or PPT)
E-Poster can be prepared in PowerPoint (one (1) PowerPoint slide) but must be saved and submitted as PDF file.
File Size: Maximum file size is 2 Megabytes (2 MB)
No hyperlinks, animated images, animations, and slide transitions
Language: English
Include your abstract number
E-posters can include QR codes, tables and photos

E-Poster

Abstract Title *

PREDICTING IGA NEPHROPATHY PROGRESSION: A HISTOPATHOLOGICAL APPROACH USING PARIETAL EPITHELIAL CELLS AND PODOCYTE MARKERS - PARCC IgAN Score

Please follow the instructions below to input your abstract title.

Abstract titles should be brief and reflect the content of the abstract.

The title will not be accepted if it exceeds 25 words.
Type in CAPITAL LETTERS.
Lowercase may be used for abbreviations only, for example, mRNA.

Co-author 1

Jean-Daniel Delbet jean-daniel.delbet@inserm.fr Inserm Paris Cardiovascular Research Centre Paris France -

Co-author 2

Marie-Cécile Perier marie-cecile.perier@inserm.fr Inserm Paris Cardiovascular Research Centre Paris France -

Co-author 3

Mathilde Baudin mathilde.baudin@aphp.fr Inserm Paris Cardiovascular Research Centre Paris France -

Co-author 4

Olivia Boyer olivia.boyer@aphp.fr Assistance Publique-Hôpitaux de Paris Dpt of pediatric nephrology, Necker Hospital Paris France -

Co-author 5

Tim Ulinski tim.ulinski@aphp.fr Assistance Publique-Hôpitaux de Paris Dpt of pediatric nephrology, Armand Trousseau Hospital Paris France -

Co-author 6

Corinne Lesaffre corine.lesaffre@inserm.fr Inserm Paris Cardiovascular Research Centre Paris France -

Co-author 7

Léa Resmini lea.resmini@inserm.fr Inserm Paris Cardiovascular Research Centre Paris France -

Co-author 8

Jean-Philippe Empana jean-philippe.empana@inserm.fr Inserm Paris Cardiovascular Research Centre Paris France -

Co-author 9

Alexandre Karras alexandre.karras@aphp.fr Assistance Publique-Hôpitaux de Paris, Inserm Departement of Nephrology, Georges Pompidou European and Paris Cardiovascular Research Centre Paris France -

Co-author 10

David Buob david.buob@aphp.fr Assistance Publique-Hôpitaux de Paris Department of Pathology, Tenon Hospital Paris France -

Co-author 11

Chloé Broudin chloe.broudin@aphp.fr Assistance Publique-Hôpitaux de Paris Department of pathology, Georges Pompidou European Paris France -

Co-author 12

Geoffrey Teixeira Geoffrey.Teixeira@alentis.ch Alentis Therapeutics Department of Fibrosis R&D Basel Switzerland -

Co-author 13

Olivia Lenoir olivia.lenoir@inserm.fr Inserm, Université Paris Cité Paris Cardiovascular Research Centre Paris France -

Co-author 14

Marion Rabant marion.rabant@aphp.fr Assistance Publique-Hôpitaux de Paris Department of pathology, Necker Hospital Paris France -

Co-author 15

Pierre-Louis Tharaux pierre-louis.tharaux@inserm.fr Inserm, Université Paris Cité Paris Cardiovascular Research Centre Paris France *